2. Paste this code immediately after the opening tag:
March 14, 2019
En los medios

New medication for treatment of Chagas disease

 

Mundo Sano, and the pharmaceutical company Elea Phoenix, organized an event to present ABARAX (benznidazol) 12.5 mg, a dose suitable for treatment of pediatric populations.
Among other attendants, doctors Silvia Gold, president, Mundo Sano; Patricia Angeleri, National Ministry of Health; Jaime Altcheh, ‘Dr. R. Gutierrez’ Children Hospital and PAHO/WHO;  Sergio Sosa Estani, DNDi, and ‘licenciados’ Marcelo Abril, Mundo Sano, and Luis Ferrero, Elea Phoenix, took part in the presentation providing their vision on the significance of having a medication specifically formulated for children treatment. They also highlighted the start of a new era which began to be built in 2011 and will stick to the commitment to the joint effort to contribute to the transformation of the lives of people suffering from this illness.

Other National Health Ministry officials, renowned infectologists, representatives of municipal administrations of the Buenos Aires province, Insud managers and Mundo Sano associates were also present at the meeting.

[ssba url="https://www.mundosano.org/en/new-medication-for-treatment-of-chagas-disease/" title="New medication for treatment of Chagas disease"]

Te puede interesar

Mar, 2021

Dengue Campaign

On the occasion of the World Dengue Day (August 26), the Consejo Publicitario Argentino (Argentine Advertising Council), supported by the assessment of Mundo Sano Foundation and the creativity of Agencias Independientes (Independent Agencies, Ai), conducted a campaign to raise awareness about this disease and promote measures to avoid the reproduction of the disease-transmitting mosquito.   Buenos Aires, August […]

Ver más >
Dec, 2020

In San Antonio de Areco, Buenos Aires province

In San Antonio de Areco, Buenos Aires province An integral epidemiological approach programme successfully avoided the community virus circulation of COVID-19 The incidence rate of COVID-19 infection was 216 per 10,000 inhabitants, with a fatality rate of 1.7% and specific mortality of 3.9 per 10,000. Compared with 2019, excess mortality was negative, with 6 fewer […]

Ver más >